Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Accounts Payables: 2022-2023

  • Lexeo Therapeutics' Accounts Payables was N/A to $2.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2022, which is N/A change from last year.
  • Per Lexeo Therapeutics' latest filing, its Accounts Payables stood at $2.7 million for Q3 2023, which was down 0.86% from $2.7 million recorded in Q4 2022.
  • In the past 5 years, Lexeo Therapeutics' Accounts Payables ranged from a high of $2.7 million in Q4 2022 and a low of $2.7 million during Q3 2023.
  • Its 2-year average for Accounts Payables is $2.7 million, with a median of $2.7 million in 2022.